首页> 美国政府科技报告 >Alteration of the Endothelial Barrier by Breast Cancer Cells as a Mechanism of Tumor Resistance
【24h】

Alteration of the Endothelial Barrier by Breast Cancer Cells as a Mechanism of Tumor Resistance

机译:乳腺癌细胞作为肿瘤耐药机制改变内皮屏障

获取原文

摘要

The endothelial cells lining blood vessels that perfuse breast tumors present a barrier that antineoplastic agents must cross to reach the tumor cells. The purpose of this award was to provide preliminary data to support the hypothesis that tumor cells can modulate this barrier by secreting soluble factors, by affecting extracellular matrix, or by a combination of these factors. The specific aims of this project were to (1) determine tumor cell induced expression of multi-drug-resistance proteins in endothelial cells; and (2) determine tumor cell mediated changes in Adriamycin transport across endothelial cells. Experiments performed to address aim 1 revealed no tumor mediated increases in p-gp protein (a classic multi-drug resistance protein) in endothelial cells.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号